tirzepatide type 1 diabetes trial Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist in patients with 2 (SURPASS-1): a double-blind, randomised, phase 3 SURPASS-CVOT Published: Large Trial Confirms

351,352 Dornase Alfa is a recombinant human deoxyribonuclease I that degrades extracellular DNA and has mucolytic properties

CAR T cells of LTR show high immunometabolic polyfunctionality post-infusion supported by the bone marrow (BM) microenvironment To study the relationship between immunometabolism and CAR T cell anti-tumor activity in patients, we examined day 28 post-infusion BM samples (Fig

This is not to say it is a wonder drug, though, as the National Library of Medicine notes, it has been known to cause tumors in lab animals, but it remains unclear if it causes a higher risk in humans

Why it matters: Unlike CRP which reflects whole-body inflammation, calprotectin is gut-specific

4 Anisimov & Khavinson, review (PubMed)Peptide bioregulation of ageing: overview of short peptides

Notably, he did not dismiss micro-dosing, the use of smaller-than-labeled doses